We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$200M
AUM Growth
+$10.8M
Cap. Flow
+$7.49M
Cap. Flow %
3.75%
Top 10 Hldgs %
28.07%
Holding
82
New
7
Increased
34
Reduced
30
Closed
4

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$2.9M
2
CERN
Cerner Corp
CERN
+$2.81M
3
HON icon
Honeywell
HON
+$2.14M
4
COST icon
Costco
COST
+$2M
5
AYI icon
Acuity Brands
AYI
+$1.87M

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$3.01M
2
NVO
Novo Nordisk
NVO
+$2.18M
3
DHR icon
Danaher
DHR
+$1.41M
4
GILD icon
Gilead Sciences
GILD
+$1.18M
5
NVS icon
Novartis
NVS
+$994K

Sector Composition

Rank Sector Weight
1 Technology 25.8%
2 Healthcare 22.33%
3 Industrials 10.96%
4 Consumer Discretionary 8.33%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNGT
76
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$251K 0.13%
8,750
NBL
77
DELISTED
Noble Energy, Inc.
NBL
$206K 0.1%
5,750
AES icon
78
AES
AES
$10.5B
$164K 0.08%
+12,800
New +$159K
GILD icon
79
Gilead Sciences
GILD
$162B
-14,195
Closed -$1.18M
NVS icon
80
Novartis
NVS
$293B
-13,450
Closed -$994K
VZ icon
81
Verizon
VZ
$195B
-3,972
Closed -$222K
RAI
82
DELISTED
Reynolds American Inc
RAI
-4,158
Closed -$224K

Similar funds

Carderock Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Carderock Capital Management held 82 positions worth $200M, up 5.7% from $189M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Carderock Capital Management deployed $7.49M of net new capital in Q3 2016, opening 7 new positions and adding to 34 existing holdings. Its largest new stake was Labcorp: 24,590 shares worth $2.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Stericycle Inc, an estimated $3.01M trimmed.

  • Carderock Capital Management's largest Q3 2016 buy was Labcorp: 24,590 shares worth $2.9M.
  • Carderock Capital Management added most to Honeywell in Q3 2016, an estimated $2.14M increase.
  • Carderock Capital Management's biggest Q3 2016 reduction was Stericycle Inc, cutting an estimated $3.01M.
  • Carderock Capital Management fully exited Gilead Sciences in Q3 2016, selling an estimated $1.18M.
  • Carderock Capital Management's ten largest holdings make up 28% of its $200M portfolio in Q3 2016.
  • Carderock Capital Management opened 7 new positions and closed 4 in Q3 2016.
  • Carderock Capital Management's portfolio value rose 5.7% quarter-over-quarter to $200M.

Based on Carderock Capital Management's 13F filing for Q3 2016, filed 2 Nov 2016.